ESC 365 - Smooth muscle cell-specific deletion of S100A4 reroutes smooth muscle cell fate and modifies the inflammatory status of murine atherosclerotic lesions

CBS PREMIUM ACCESS

Smooth muscle cell-specific deletion of S100A4 reroutes smooth muscle cell fate and modifies the inflammatory status of murine atherosclerotic lesions

Session: Moderated poster 12 - Vascular Diseases

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Doctor L. Cardoso dos Santos (Geneva, CH)

Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

About the speaker

Doctor Luis Miguel Cardoso dos Santos

University of Geneva, Geneva (Switzerland)

0 follower

4 more presentations in this session

Targeting BACE1 to restore functional angiogenesis in type 2 diabetes

Speaker: Miss E. Clavane (Leeds, GB)

Understanding the role of RIPK1 kinase activity in atherogenesis: a genetic versus pharmacological approach

Speaker: Ms P. Puylaert (Antwerp, BE)

Focused ultrasound-induced targeted delivery of miR-155-5p inhibitor employing biomimetic microbubbles reduces NADPH oxidase expression and inflammation in atherosclerotic ApoE-/- mice

Speaker: Doctor A. Manea (Bucharest, RO)

Necroptosis, unlike pyroptosis mediates right ventricular damage in pulmonary arterial hypertension

Speaker: Miss I. Jarabicova (Bratislava, SK)

Access the full session

Moderated poster 12 - Vascular Diseases

Speakers: Doctor L. Cardoso dos Santos, Miss E. Clavane, Ms P. Puylaert, Doctor A. Manea, Miss I. Jarabicova

About the event

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress

ESC 365 is supported by